Free Trial

Short Interest in TerrAscend Corp. (OTCMKTS:TSNDF) Increases By 18.7%

TerrAscend logo with Medical background

TerrAscend Corp. (OTCMKTS:TSNDF - Get Free Report) saw a significant growth in short interest in the month of October. As of October 15th, there was short interest totalling 2,022,200 shares, a growth of 18.7% from the September 30th total of 1,704,000 shares. Based on an average daily volume of 245,700 shares, the short-interest ratio is currently 8.2 days.

TerrAscend Trading Down 2.7 %

Shares of TSNDF traded down $0.03 during midday trading on Tuesday, hitting $1.09. 228,007 shares of the stock traded hands, compared to its average volume of 339,282. The business's 50 day moving average price is $1.23 and its two-hundred day moving average price is $1.41. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.69 and a current ratio of 1.35. TerrAscend has a 1-year low of $1.07 and a 1-year high of $2.45.

TerrAscend (OTCMKTS:TSNDF - Get Free Report) last posted its quarterly earnings data on Thursday, August 8th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.01). TerrAscend had a negative return on equity of 31.48% and a negative net margin of 23.95%. The company had revenue of $77.52 million during the quarter, compared to analyst estimates of $80.70 million. Analysts forecast that TerrAscend will post -0.14 earnings per share for the current year.

Analyst Ratings Changes

Separately, Ventum Cap Mkts raised shares of TerrAscend to a "strong-buy" rating in a research report on Friday, August 9th.

Check Out Our Latest Research Report on TSNDF

About TerrAscend

(Get Free Report)

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.

Further Reading

→ This company will win the AI race (From Porter & Company) (Ad)

Should you invest $1,000 in TerrAscend right now?

Before you consider TerrAscend, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TerrAscend wasn't on the list.

While TerrAscend currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Whitestone REIT is Outperforming in 2024: 35% Growth & Monthly Dividends
Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines